Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
Poster
P017
ePoster
Use of Rimegepant 75 mg for the acute treatment of migraine is associated with a reduction in monthly migraine days – a pooled analysis of 2 open-label trials
Presented in
ePoster 02
Poster topics
New clinical developments in prophylactic and acute medications
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy